Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) Debt to Equity (2018 - 2026)

Exagen filings provide 9 years of Debt to Equity readings, the most recent being $1.58 for Q1 2026.

  • On a quarterly basis, Debt to Equity fell 51.54% to $1.58 in Q1 2026 year-over-year; TTM through Mar 2026 was $1.58, a 51.54% decrease, with the full-year FY2025 number at $1.31, down 38.14% from a year prior.
  • Debt to Equity hit $1.58 in Q1 2026 for Exagen, up from $1.31 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $3.27 in Q1 2025 to a low of $0.36 in Q1 2022.
  • Median Debt to Equity over the past 5 years was $0.98 (2024), compared with a mean of $1.14.
  • Biggest five-year swings in Debt to Equity: skyrocketed 234.63% in 2025 and later tumbled 51.54% in 2026.
  • Exagen's Debt to Equity stood at $0.68 in 2022, then rose by 25.91% to $0.86 in 2023, then skyrocketed by 147.03% to $2.12 in 2024, then crashed by 38.14% to $1.31 in 2025, then grew by 20.71% to $1.58 in 2026.
  • The last three reported values for Debt to Equity were $1.58 (Q1 2026), $1.31 (Q4 2025), and $1.26 (Q3 2025) per Business Quant data.